ACLS Provider: Course

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. Adenosine is the first-line drug for treating narrow-complex SVT by slowing conduction through the AV node.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. Hypothermia is a potentially reversible cause of cardiac arrest and should be addressed during resuscitation.

Incorrect. Hypoxia is a reversible cause of PEA; it must be treated immediately with oxygenation and ventilation.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.

Incorrect. Epinephrine is administered every 3-5 minutes during cardiac arrest to maximize coronary and cerebral perfusion.

Incorrect. Thrombosis (pulmonary or coronary) is a reversible cause of cardiac arrest and should be addressed immediately.

Incorrect. Reduces the risk of oxidative stress and worsened outcomes by preventing hyperoxia.

Incorrect. Early defibrillation within 30 seconds of a witnessed VF arrest increases survival rates significantly.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for torsades de pointes.

Incorrect. Two rescuers are needed to maintain high-quality CPR with an advanced airway: one for compressions and one for ventilation.

Incorrect. A compression fraction above 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be completed before checking the rhythm.

Incorrect. With an advanced airway in place, compressions should continue uninterrupted while providing 10 breaths per minute.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be addressed during resuscitation efforts.

Incorrect. The maximum dose of atropine for bradycardia is 3 mg, with doses given at 0.5 mg intervals every 3-5 minutes.

Incorrect. These shockable rhythms require immediate defibrillation to restore a perfusing rhythm.

Incorrect. With an advanced airway in place, uninterrupted compressions improve blood flow while ventilation is delivered separately.

Incorrect. Pausing compressions for more than 10 seconds interrupts perfusion and reduces the chances of ROSC.

Incorrect. Epinephrine is the first-line drug for VF, with amiodarone as the preferred antiarrhythmic for refractory cases.

Incorrect. Two minutes of CPR (about 5 cycles of 30 compressions and 2 breaths) should be performed before reassessing the rhythm.

Incorrect. With an advanced airway in place, compressions continue uninterrupted while breaths are delivered at 6-8 breaths per minute.

Incorrect. A left lateral tilt prevents aortocaval compression, improving venous return and cardiac output during resuscitation.

Incorrect. Pulseless VT is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. Positioning the patient with a slight left tilt prevents aortocaval compression and improves venous return during CPR.

Incorrect. Epinephrine is repeated every 3-5 minutes during cardiac arrest to enhance perfusion pressure.

Incorrect. Atropine is the first-line treatment for symptomatic bradycardia, increasing the heart rate by blocking vagal stimulation.

Incorrect. Symptomatic second-degree AV block type II can progress to complete heart block, requiring pacing.

Incorrect. Pulse checks are performed every 2 minutes during rhythm assessments to evaluate the effectiveness of resuscitation.

Incorrect. Adenosine is used to terminate reentrant arrhythmias in narrow-complex SVT by slowing conduction through the AV node.

Incorrect. Hypoxia is the most frequent reversible cause of PEA and should be addressed immediately with oxygenation and ventilation.

Incorrect. TTM helps reduce neurological injury after ROSC by maintaining a target temperature between 32-36°C.

Incorrect. Interruptions in chest compressions should not exceed 10 seconds to maintain adequate perfusion to vital organs.

Incorrect. Compressing the chest 2-2.4 inches ensures adequate blood flow while minimizing injury risks.

Incorrect. Adenosine is used for narrow-complex SVT, not wide-complex tachycardia, which is typically treated with amiodarone.

Incorrect. Synchronized cardioversion is indicated for unstable atrial fibrillation to restore sinus rhythm and prevent hemodynamic collapse.

Incorrect. Amiodarone stabilizes the myocardium and is given as a bolus for refractory VF or pulseless VT.

Incorrect. Naloxone blocks opioid receptors and is administered to reverse opioid overdose and restore adequate respiration.

Incorrect. Waveform capnography ensures proper ET tube placement by continuously monitoring exhaled CO? levels.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. A compression fraction greater than 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. Rescuers should switch every 2 minutes to prevent fatigue and ensure high-quality compressions are maintained.

Incorrect. Administered via rapid IV push, followed by a saline flush to terminate reentrant arrhythmias.

Incorrect. Epinephrine 1 mg IV/IO is administered every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Maintaining oxygen saturation at 92-96% avoids hypoxia while preventing hyperoxia, which can cause further tissue damage.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. Ventricular fibrillation is the most common cause of sudden cardiac arrest and requires immediate defibrillation.

Incorrect. Delivering 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. Delivering 6-8 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. Amiodarone is the preferred antiarrhythmic for stabilizing wide-complex tachycardia in stable patients.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during cardiac arrest.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and must be corrected to restore spontaneous circulation.

Incorrect. Adenosine is administered as a 0.1 mg/kg rapid IV push for pediatric SVT, followed by a saline flush.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. Maintaining this range prevents hypoxia while minimizing the risks of hyperoxia and oxidative injury.

Incorrect. A PETCO2 level greater than 10 mmHg indicates that chest compressions are generating adequate blood flow.

Incorrect. Pediatric defibrillation begins at 2 J/kg and increases to 4 J/kg for subsequent shocks if needed.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Compressing to one-third the depth of the chest ensures adequate perfusion while minimizing the risk of injury.